US2001034319A1PendingUtilityA1

Photothermal vascular targeting with bioreductive agents

Priority: Mar 23, 1999Filed: Jun 4, 2001Published: Oct 25, 2001
Est. expiryMar 23, 2019(expired)· nominal 20-yr term from priority
A61B 18/203A61N 5/062A61N 2005/0645A61B 2018/00458A61B 2018/00452
37
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method of selectively enhancing the effect of photothermal vascular targeting on tumor regression by administration of a bioreductive agent is disclosed.

Claims

exact text as granted — not AI-modified
What is claimed is:  
     
         1 . A method of treating a tumor characterized by nutrient-providing blood vessels comprising 
 irradiating the tumor or nutrient providing blood vessels in the presence of a bioreductive agent,    providing an environment of hypoxia for the bioreductive agent, and    allowing the bioreductive agent to act as a cytotoxic agent in a manner to reduce tumor size.

Join the waitlist — get patent alerts

Track US2001034319A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.